Medicine and Dentistry
Inflammatory Bowel Disease
81%
Endoscopic Ultrasound
70%
Esophageal Cancer
67%
Biological Marker
48%
Crohn's Disease
47%
Disease
44%
Patient with Crohn's Disease
27%
Positron Emission Tomography
25%
Infliximab
23%
Chronic Pancreatitis
22%
Ulcerative Colitis
21%
Disease Activity
21%
Patient with Inflammatory Bowel Disease
20%
Pancreatitis
20%
Extracellular Matrix
20%
Positron Emission Tomography
20%
Neoplasm
18%
Collagen Type 4
18%
Quality of Life
16%
Tumor Necrosis Factor
16%
Vedolizumab
15%
Magnetic Resonance Imaging
15%
Collagen Type 1
14%
Treatment Response
14%
Computer Assisted Tomography
14%
Collagen Degradation
14%
Randomized Controlled Trial
13%
Surgery
13%
Endoscopic Retrograde Cholangiopancreatography
13%
Esophagus Carcinoma
13%
Fluorodeoxyglucose
12%
Pancreatic Cysts
11%
Diagnosis
11%
Conservative Treatment
11%
Fine-Needle Aspiration
11%
Health Care Cost
11%
Neutrophil
11%
Esophagus
10%
Fluorodeoxyglucose F 18
10%
False Positive Result
10%
Symptomatic Treatment
10%
Symptom
9%
Combination Therapy
9%
Distant Metastasis
9%
Anal Sphincterotomy
9%
Chemoradiotherapy
8%
Proteomics
8%
Pancreas Cancer
8%
Pylorus Stenosis
8%
Gut Microbiota
8%
Immunology and Microbiology
Inflammatory Bowel Disease
100%
Crohn's Disease
73%
Ulcerative Colitis
27%
Infliximab
21%
Extracellular Matrix
20%
Vedolizumab
15%
Epitope
15%
Tumor Necrosis Factor
15%
Neutrophil
14%
Immunoprecipitation
13%
Collagen Degradation
12%
Microflora
12%
Azathioprine
9%
Antibody Blood Level
9%
Pancreatitis
8%
Bacteriophage
8%
Intestine Flora
7%
Colitis
7%
Antibody Response
6%
Colon
6%
Enteritis
6%
C-Reactive Protein
6%
Prevalence
5%
Computer Assisted Tomography
5%
TLR4
5%
Multidrug Resistance Protein 1
5%
Antiinflammatory Activity
5%
Keyphrases
Inflammatory Bowel Disease
70%
Crohn's Disease
28%
Infliximab
13%
Disease Activity
11%
Ulcerative Colitis
11%
Type I Collagen
10%
Clinical Phenotype
9%
Intestinal Transplantation
8%
Induction Therapy
8%
Endoscopic Disease Activity
8%
Co-immunoprecipitation (co-IP)
8%
Antibody Epitope
8%
Host-microbe Interactions
8%
Fecal Calprotectin
7%
Collagen Degradation
7%
Inflammation
6%
Type III Collagen
6%
Intestinal Failure
5%
Specific Antibodies
5%
Staged Strategy
5%
Antibody Signature
5%
Serum Biomarkers
5%
Gut Microbiota
5%
Biological Therapy
5%
Transcriptional Network
5%
Disease Location
5%
Gut Microbiota Composition
5%
Mucosal Inflammation
5%
Microbial Composition
5%
